If the UK leaves the EU in March without a deal, transport of insulin and other essential drugs could be delayed.

Patients will be able to access the drug with a prescription, and there are no plans to allow for recreational use.

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

Input lines are open for the National Institute of Substance Use and Addiction Disorders.

After a lightning-fast approval, the first medicine to treat an underlying cause of the disorder hits the market.

A list of this year’s newsworthy successes—and failures—in drug development

The pharmaceutical darling that has brought billions in revenue to Pfizer over the past 15 years will now share the shelves with its generic competitors.

Forensic labs in the United States should be better equipped to identify a new crop of recreational drug mimics.